Cochlear Limited Market Share Analysis

Summary

GlobalData’s new report, “Cochlear Limited Market Share Analysis” provides in-depth information on Cochlear Limited’s market position in the different medical equipment markets it operates in. The report provides Cochlear Limited market share information in one key market category – Hearing Implants. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Cochlear Limited operates in – ENT Devices.

- Cochlear Limited’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, China, Japan, India, Spain, Italy, United Kingdom, Germany, France, Canada, United States and Brazil.

- Cochlear Limited’s company shares (in Revenues) information for all the key market category the company has presence in –. Hearing Implants

- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.

- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.

- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..

- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Cochlear Limited operates in.

- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.

- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.

- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.

- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cochlear Limited’s market positions.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

3 Definitions of Markets/Categories Covered 8

3.1 ENT Devices 8

3.1.1 Hearing Implants 8

4 Company Snapshot 9

4.1 Key Information 9

4.2 Company Overview 9

4.3 Financial Performance 9

4.4 SWOT Snapshot 9

5 Business Description 10

5.1 Business Overview 10

5.2 Implantable Hearing Devices 10

5.2.1 Overview 10

5.2.2 Financials 10

5.2.3 Market View 10

5.3 Major Products and Services 11

5.3.1 Overview 11

6 History 12

7 Business Strategy 16

7.1 Mission Statement 16

8 SWOT Analysis 16

8.1 Overview 16

8.2 Cochlear Limited Strengths 17

8.2.1 Focused Research and Development Activities 17

8.2.2 Geographical Diversity 17

8.2.3 Constant Growth in Revenues 17

8.3 Cochlear Limited Weaknesses 17

8.3.1 Patent Infringement Claims 17

8.3.2 Product Recalls 17

8.4 Cochlear Limited Opportunities 18

8.4.1 Growing Aged Population 18

8.4.2 Global ENT Devices Market 18

8.4.3 Industry Recognitions 18

8.5 Cochlear Limited Threats 19

8.5.1 Technological Developments 19

8.5.2 Inherent Market Factor 19

8.5.3 Stringent Regulations 19

9 Competitors 20

10 Competitive Landscape 21

10.1 ENT Devices (Hearing Implants), Global, Market Share (%), 2011 21

10.2 Cochlear Limited, ENT Devices(Hearing Implants), by Region, Market Share (2011) 22

10.3 Cochlear Limited, ENT Devices (Hearing Implants), by Country, Market Share (2011) 24

11 Share Holding Structure 26

12 Key Employees 27

13 Key Employee Biographies 28

14 Company Statement 29

15 Locations And Subsidiaries 31

15.1 Head Office 31

15.2 Other Locations & Subsidiaries 31

16 Financial Deals Landscape 34

16.1 Cochlear Limited, Deals Volume Summary, 2006 to YTD 2012 34

17 Cochlear Limited Detailed Deal Summary 36

17.1 Asset Purchase 36

17.1.1 Cochlear To Acquire Technology Rights From Otologics 36

17.2 Partnerships 37

17.2.1 GN ReSound Enters Into Licensing Agreement With Cochlear 37

18 Recent Developments 38

18.1 Strategy And Business Planning 38

18.1.1 Aug 13, 2010: Cochlear Sets Up New Subsidiary In India 38

18.1.2 Oct 14, 2009: Cochlear And NXP Collaborate To Enable Cochlear’s Next Generation Hearing Implant Products 38

18.2 Financial Announcements 39

18.2.1 Aug 09, 2011: Cochlear Reports Total Revenue Of AUD809.6m In Fiscal 2011 39

18.2.2 Feb 08, 2011: Cochlear Reports H1 Fiscal Year Ended 2011 Results 39

18.2.3 Aug 10, 2010: Cochlear Reports Total Revenue Of AUD734.8m In Fiscal Year Ended 2010 40

18.2.4 Feb 09, 2010: Cochlear Reports H1 Fiscal Year Ended 2010 Results 40

18.2.5 Aug 11, 2009: Cochlear Reports Total Revenues Of AUD694.7 Million For Fiscal 2009 41

18.2.6 Jul 13, 2009: Cochlear Provides Guidance For Fiscal 2009 43

18.2.7 Feb 10, 2009: Cochlear Reports H1 Fiscal 2009 Results 44

18.2.8 Aug 12, 2008: Cochlear Reports Fiscal 2008 Results 47

18.2.9 Feb 12, 2008: Cochlear Reports H1 Fiscal 2008 Results 48

18.2.10 Aug 14, 2007: Cochlear Declares Final Dividend 50

18.2.11 Aug 14, 2007: Cochlear Reports Fiscal 2007 Results 50

18.2.12 Feb 13, 2007: Cochlear Reports H1 Fiscal 2007 Results 51

18.2.13 Aug 15, 2006: Cochlear Reports Fiscal 2006 Results 51

18.3 Corporate Communications 52

18.3.1 Aug 02, 2010: Cochlear Appoints Yasmin Allen As Non-Executive Director 52

18.3.2 Mar 17, 2010: Cochlear Announces Retirement Of Tommie Bergman As Chairman And Non-Executive Director 52

18.3.3 Dec 15, 2006: Cochlear Appoints New Board Member 52

18.3.4 Jul 18, 2006: Cochlear Board Members To Retire 53

18.4 Product News 53

18.4.1 May 02, 2012: Cochlear Americas Adds Nucleus Support App To Its Mobile Service Offerings 53

18.4.2 Jun 23, 2010: Cochlear Receives FDA Approval For Cochlear Nucleus 5 Rechargeable Battery System 53

18.4.3 Mar 29, 2010: Cochlear To Complete Clinical Trial For Cochlear Nucleus 5 In First Quarter Of 2012 54

18.4.4 Sep 04, 2009: Cochlear Announces FDA Approval For Cochlear Nucleus 5 System 54

18.4.5 Jul 10, 2009: Cochlear Americas Receives US FDA Clearance For Cochlear Baha BP100 Sound Processor 54

18.4.6 Jul 25, 2008: Cochlear Announces Milestone In Hearing Restoration With 120,000 Nucleus Cochlear Implants 55

18.5 Product Approvals 55

18.5.1 Jun 23, 2010: Cochlear Receives FDA Approval For Cochlear Nucleus 5 Rechargeable Battery System 55

18.5.2 Sep 04, 2009: Cochlear Announces FDA Approval For Cochlear Nucleus 5 System 55

18.5.3 Jul 10, 2009: Cochlear Americas Receives US FDA Clearance For Cochlear Baha BP100 Sound Processor 56

18.6 Clinical Trials 57

18.6.1 Mar 29, 2010: Cochlear To Complete Clinical Trial For Cochlear Nucleus 5 In First Quarter Of 2012 57

18.7 Other Significant Developments 57

18.7.1 Jul 11, 2010: Cochlear To Spend $15 Million Over Five Years In India 57

18.7.2 Jun 03, 2009: Watpac bags Cochlear headquarters project in Australia 58

18.7.3 Jun 03, 2009: Cochlear Announces Conclusion Of Agreements For New Global Headquarters 58

19 Appendix 59

19.1 Research Methodology 60

19.2 Secondary Research 60

19.3 Primary Research 60

19.4 Models 61

19.5 Forecasts 61

19.6 Expert Panels 61

19.7 GlobalData Consulting 61

19.8 Currency Conversion 62

19.9 Contact Us 63

19.10 Disclaimer 63

1.1 List of Tables

Table 1: Cochlear Limited, Key Facts, 2011 9

Table 2: Cochlear Limited, SWOT Analysis, 2011 16

Table 3: ENT Devices (Hearing Implants), Global, Company Share by Revenue ($m), 2011 21

Table 4: Cochlear Limited, ENT Devices (Hearing Implants), by Region, Revenue ($m) and Market Share (%), 2011 23

Table 5: Cochlear Limited, ENT Devices (Hearing Implants), by Country, Revenue ($m) and Market Share (%), 2011 25

Table 6: Cochlear Limited, Share Holding Structure 26

Table 7: Cochlear Limited, Key Employees 27

Table 8: Cochlear Limited, Other Locations 31

Table 9: Cochlear Limited, Subsidiaries 31

Table 10: Cochlear Limited, Deals Volume Summary, 2006 to YTD 2012 34

Table 11: Cochlear Limited, Deals Summary, 2006 to YTD 2012 35

Table 12: Cochlear To Acquire Technology Rights From Otologics 36

Table 13: GN ReSound Enters Into Licensing Agreement With Cochlear 37

Table 14: USD to Local Currency, Average Exchange Rate, 2011 62

1.2 List of Figures

Figure 1: ENT Devices (Hearing Implants), Global, Market Share (%), 2011 21

Figure 2: Cochlear Limited, ENT Devices (Hearing Implants), by Region, Market Share (%), 2011 22

Figure 3: Cochlear Limited, ENT Devices (Hearing Implants), by Country, Market Share (%), 2011 24

Figure 4: Cochlear Limited, Deals Volume Summary, 2006 to YTD 2012 34